WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday, January 23, 2025 at 4:15pm Eastern ...

Zhengye Biotechnology closed a $6 million IPO ... shares have been listed on the Nasdaq Capital Market under the ticker symbol "ZYBT," enhancing its visibility and credibility in the investment ...

The Bay Area-based biotech revealed the planned IPO in a Jan ... Maze applied to be listed on the Nasdaq under the ticker symbol "MAZE," according to the filing. Analysts predict M&A, IPO uptick ...

1) The biotech industry is due for accelerating M&A activity due to extremely low valuations of many small-cap biotechs and the need of the big pharma boys to compensate for big upcoming losses of ...

Biotechnology contributes to this aspect of the plastics industry while providing end-of-life waste management solutions via enzymatic recycling, facilitating monomer recovery under milder conditions ...

Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share. The shares have been approved for listing on the Nasdaq and are expected ...

Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic ... Shares of Clearmind are listed for trading on Nasdaq under ...

Re­gen­eron, mak­er of the block­buster oph­thal­mol­o­gy med­i­cine Eylea, has ac­quired an oc­u­lar biotech, the large bio­phar­ma con­firmed to End­points News on Thurs­day.

2024 was the year of the pri­vate megaround. Nine-fig­ure fi­nanc­ings dom­i­nat­ed biotech’s ven­ture fund­ing land­scape, with 96 such rounds tal­lied by End­points News. The bevy … ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

Making its debut on 01/31/2006, smart beta exchange traded fund SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs?

Local biotech Heron Therapeutics is relocating its headquarters from San Diego to North Carolina, where it says the area’s burgeoning biotech scene “provides ample space for growth and ...